SCHEMBL16079168

SCHEMBL16079168

C=C/C=C(\C)C(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263279 0.81 ALDH1A1 (0.33)
SCHEMBL7263274 0.81 ALDH1A1 (0.33)
SCHEMBL14886943 0.78
SCHEMBL15774037 0.78
SCHEMBL16581262 0.76
SCHEMBL9768535 0.74 ALOX15 (0.35)
SCHEMBL30558768 0.74 CES1 (0.48)
SCHEMBL22386310 0.74
SCHEMBL9768533 0.74 ALOX15 (0.35)
SCHEMBL16581266 0.74 CES1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed
EP-3822268-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2021-05-19 EP disclosed
US-20140271765-A1 METHODS AND DEVICE FOR TREATING OPIOID ADDICTION TITAN PHARMACEUTICALS, INC. (US) 2014-09-18 US disclosed